NCT06474091 2026-03-16Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)Mayo ClinicEnrolling by invitation100 enrolled
NCT06506955 2026-03-11Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.Taiho Oncology, Inc.Phase 2/3 Enrolling by invitation15 enrolled